JPS62502168A - 連続酸素供給システム - Google Patents
連続酸素供給システムInfo
- Publication number
- JPS62502168A JPS62502168A JP60505374A JP50537485A JPS62502168A JP S62502168 A JPS62502168 A JP S62502168A JP 60505374 A JP60505374 A JP 60505374A JP 50537485 A JP50537485 A JP 50537485A JP S62502168 A JPS62502168 A JP S62502168A
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- oxygen
- tube
- trachea
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052760 oxygen Inorganic materials 0.000 title claims description 136
- 239000001301 oxygen Substances 0.000 title claims description 136
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims description 135
- 210000003437 trachea Anatomy 0.000 claims description 104
- 238000000034 method Methods 0.000 claims description 28
- 238000004140 cleaning Methods 0.000 claims description 25
- 238000003780 insertion Methods 0.000 claims description 23
- 230000037431 insertion Effects 0.000 claims description 23
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 16
- 210000000621 bronchi Anatomy 0.000 claims description 14
- 238000002640 oxygen therapy Methods 0.000 claims description 14
- 210000004400 mucous membrane Anatomy 0.000 claims description 13
- 230000003444 anaesthetic effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 8
- 230000002787 reinforcement Effects 0.000 claims description 8
- 206010021143 Hypoxia Diseases 0.000 claims description 6
- 230000001684 chronic effect Effects 0.000 claims description 6
- 230000006378 damage Effects 0.000 claims description 5
- 208000018875 hypoxemia Diseases 0.000 claims description 5
- 210000004379 membrane Anatomy 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 239000012779 reinforcing material Substances 0.000 claims description 5
- 229920002457 flexible plastic Polymers 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000011866 long-term treatment Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 210000003685 cricoid cartilage Anatomy 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000002792 vascular Effects 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 238000005452 bending Methods 0.000 claims 1
- 239000000560 biocompatible material Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 230000001146 hypoxic effect Effects 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 210000000867 larynx Anatomy 0.000 claims 1
- 230000013011 mating Effects 0.000 claims 1
- 238000005192 partition Methods 0.000 claims 1
- 239000010421 standard material Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000007774 longterm Effects 0.000 description 14
- 238000011282 treatment Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 230000000153 supplemental effect Effects 0.000 description 6
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 5
- 238000002664 inhalation therapy Methods 0.000 description 5
- 229960004194 lidocaine Drugs 0.000 description 5
- 239000003589 local anesthetic agent Substances 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000002690 local anesthesia Methods 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000019693 Lung disease Diseases 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 206010042344 Subcutaneous emphysema Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000004868 gas analysis Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229920002633 Kraton (polymer) Polymers 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 208000011623 Obstructive Lung disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000219289 Silene Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229940098803 hibiclens Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001664 manubrium Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 210000005092 tracheal tissue Anatomy 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000005203 vein jugularis anteriores Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67391284A | 1984-11-21 | 1984-11-21 | |
| US673912 | 1984-11-21 | ||
| US788817 | 1985-10-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62502168A true JPS62502168A (ja) | 1987-08-27 |
| JPH0552752B2 JPH0552752B2 (cg-RX-API-DMAC7.html) | 1993-08-06 |
Family
ID=24704602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60505374A Granted JPS62502168A (ja) | 1984-11-21 | 1985-11-19 | 連続酸素供給システム |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62502168A (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020000451A (ja) * | 2018-06-27 | 2020-01-09 | 富士システムズ株式会社 | カテーテル |
-
1985
- 1985-11-19 JP JP60505374A patent/JPS62502168A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020000451A (ja) * | 2018-06-27 | 2020-01-09 | 富士システムズ株式会社 | カテーテル |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0552752B2 (cg-RX-API-DMAC7.html) | 1993-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5181509A (en) | Transtracheal catheter system | |
| US5186168A (en) | Transtracheal catheter system and method | |
| US5297546A (en) | Transtracheal catheter system and method | |
| Standard | National safety and quality health service standards | |
| US7195016B2 (en) | Transtracheal oxygen stent | |
| US5230332A (en) | Methods and apparatus for a micro-tracheal catheter hub assembly | |
| EP0122901B1 (en) | Instrument for the treatment of respiratory obstruction | |
| JPH06502337A (ja) | マイクロ気管カテーテル・ボス・アッセンブリー用方法及び装置 | |
| US20120266891A1 (en) | System for transtracheal administration of oxygen | |
| WO2011038951A1 (en) | Transtracheal catheter apparatus | |
| Heimlich et al. | Transtracheal catheter technique for pulmonary rehabilitation | |
| US9795770B1 (en) | Bendable nasal airway tube device and method of bending same | |
| EP0207099B1 (en) | Transtracheal catheter system | |
| JPS62502168A (ja) | 連続酸素供給システム | |
| Greenberg | Facemask, nasal, and oral airway devices | |
| GB2137506A (en) | Catheter for administering oxygen | |
| Raffe | Respiratory care | |
| US20060157061A1 (en) | Transtracheal oxygen stent | |
| CA1267343A (en) | Transtracheal catheter system and method | |
| Sierra et al. | Artificial airway management | |
| Unwin et al. | Percutaneous dilational trachestomy in the morbidly obese. | |
| Paw et al. | Percutaneous tracheostomy: a practical handbook | |
| Bodley | Development of anaesthesia for plastic surgery | |
| Corley | Procedures in the neonatal foal | |
| Diaz et al. | Percutaneous Tracheotomy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |